MedTrace Logo

Efficacy Study of Cosmetic Product RV3278AET0943 Versus Non-treated Group in Adults With Oily and Acne Prone Skin

NCT04873089 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2021-05-05

No results posted yet for this study

Summary

The aim of this study is to evaluate, at different times, the RV3278A - ET0943 cosmetic product efficacy after 8 weeks of application on the face (twice-daily application). At T1 (Baseline), T2 (4 weeks) and T3 (8 weeks), the following assessments are performed:

* The reduction of the pilosebaceous follicular ostium size in vivo (pores) on the forehead
* The clinical evaluation (count of non inflammatory and inflammatory acne lesions, IGA score) of the face
* The reduction in visible follicles
* The standardized numerical photographs of face and ¾ right and left profile in normal, parallel polarized, cross polarized and UV light
* The analysis of the skin lipids of the forehead
* The qualitative and quantitative analysis of the sebum and comedones constituents (nose wings)

This is a comparative, open-labelled study, on subjects with oily and acne prone skins on the face.

Each group includes 18 subjects.

Conditions

Interventions

OTHER

Cosmetic product

It is a comparative study with two parallel groups of subjects: * Tested group: twice daily application of the cream RV3278A cosmetic product on the whole face * Comparative group: no application of study product or reference product

Sponsors & Collaborators

  • Pierre Fabre Dermo Cosmetique

    lead INDUSTRY

Principal Investigators

  • Thérèse NOCERA, MD dermatologist · SKIN RESEARCH CENTRE - Toulouse

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-17
Primary Completion
2018-12-21
Completion
2018-12-21

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04873089 on ClinicalTrials.gov